A rating of 94 puts Curis, Inc. (CRIS) near the top of the Biotechnology industry according to InvestorsObserver. Curis, Inc.'s score of 94 means it scores higher than 94% of stocks in the industry. Curis, Inc. also received an overall rating of 63, putting it above 63% of all stocks. Biotechnology is ranked 106 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Curis, Inc. Stock Today?
Curis, Inc. (CRIS) stock is higher by 2.42% while the S&P 500 is lower by -0.96% as of 9:55 AM on Tuesday, May 11. CRIS is higher by $0.24 from the previous closing price of $9.73 on volume of 47,878 shares. Over the past year the S&P 500 has gained 41.57% while CRIS is higher by 1059.30%. CRIS lost -$0.61 per share the over the last 12 months.